Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AURELIA: Bevacizumab + Chemotherapy in Platinum-Resistant Ovarian Cancer
NCT00976911Phase 3Completed
- Sponsor
- Roche
- Start
- Oct 2009
- Primary completion
- Jul 2014
- Modality
- Monoclonal Antibodies
- Countries
- 14
01
Overview
A Phase 3 trial of bevacizumab in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Roche. Started Oct 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00976911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00976911.